Applied pharmacology to membrane biology and signal transduction mechanisms.
BioFarma
University Hospitals Bristol NHS Foundation Trust
Brístol, Reino UnidoPublications in collaboration with researchers from University Hospitals Bristol NHS Foundation Trust (1)
2014
-
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): A phase 3, multicentre, double-blind, placebo-controlled randomised trial
The Lancet Oncology, Vol. 15, Núm. 8, pp. 894-904